Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.631
+0.012 (1.97%)
At close: Nov 21, 2024, 4:00 PM
0.589
-0.042 (-6.72%)
After-hours: Nov 21, 2024, 7:55 PM EST
Chromocell Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -10.07 | -7.38 | -2.46 | -0.6 | -0.66 |
| Other Amortization | 0.74 | 0.19 | 0.14 | - | - |
| Stock-Based Compensation | 2.06 | 1.73 | 0.11 | - | - |
| Other Operating Activities | 1.86 | 2.43 | - | -0.24 | - |
| Change in Accounts Payable | 1.02 | 1.63 | 0.41 | -0.83 | -2.97 |
| Change in Other Net Operating Assets | -1.09 | 0.42 | 0.23 | 0.07 | - |
| Operating Cash Flow | -5.48 | -0.98 | -1.57 | -1.59 | -3.63 |
| Short-Term Debt Issued | - | 0.77 | 0.4 | - | 0.24 |
| Long-Term Debt Issued | - | - | 0.8 | 1.1 | - |
| Total Debt Issued | 0.87 | 0.77 | 1.2 | 1.1 | 0.24 |
| Net Debt Issued (Repaid) | 0.65 | 0.77 | 1.2 | 1.1 | 0.24 |
| Issuance of Common Stock | 6.23 | 0.26 | 0.42 | 0.49 | 3.38 |
| Financing Cash Flow | 6.71 | 1.02 | 1.62 | 1.59 | 3.63 |
| Net Cash Flow | 1.23 | 0.04 | 0.06 | - | - |
| Free Cash Flow | -5.48 | -0.98 | -1.57 | -1.59 | -3.63 |
| Free Cash Flow Margin | - | - | - | - | -1813.48% |
| Free Cash Flow Per Share | -1.20 | -0.77 | -3.60 | - | - |
| Levered Free Cash Flow | -8.4 | -0.64 | - | - | - |
| Unlevered Free Cash Flow | -8.62 | -0.5 | - | - | - |
| Change in Net Working Capital | 4.33 | -2.05 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.